-
公开(公告)号:FI89171C
公开(公告)日:1993-08-25
申请号:FI884911
申请日:1988-10-24
Applicant: HOECHST AG
Inventor: SCHWAB WILFRIED , BARTLETT ROBERT RYDER , GENERT ULRICH , SCHORLEMMER HANS ULRICH , DICKNEITE GERHARD , SEDLACEK HANS HARALD
IPC: A61K31/675 , A61K39/39 , A61P35/00 , A61P37/00 , C07F9/40 , C07F9/547 , C07F9/653 , C07F9/6574
-
公开(公告)号:DK166282C
公开(公告)日:1993-08-23
申请号:DK224284
申请日:1984-05-04
Applicant: HOECHST AG
Inventor: SCHWAB WILFRIED , DUERCKHEIMER WALTER , KIRRSTETTER REINER , LATTRELL RUDOLF
IPC: C07D501/04 , A61K31/425 , A61K31/545 , C07D20060101 , C07D501/00 , C07D501/06 , C07D501/38 , C07D501/46 , C07D501/56 , C07D501/57
Abstract: Process for the preparation of cephem compounds of the formula
-
公开(公告)号:AU6716090A
公开(公告)日:1991-06-26
申请号:AU6716090
申请日:1990-11-17
Applicant: HOECHST AG
Inventor: LOHER HEINZ JOSEF , SCHWAB WILFRIED , BAUER KLAUS , BIERINGER HERMANN
IPC: A01N25/32 , A01N55/10 , C07D261/04
-
公开(公告)号:FI911718A0
公开(公告)日:1991-04-10
申请号:FI911718
申请日:1991-04-10
Applicant: HOECHST AG
Inventor: SCHWAB WILFRIED , ANAGNOSTOPULOS HIRISTO , PORSCHE-WIEBKING ELENA , GROME JOHN
IPC: A61K31/415 , A61K31/44 , A61K31/445 , A61K31/675 , A61P9/10 , A61P25/08 , A61P25/18 , A61P25/28 , C07D261/04 , C07D261/08 , C07D261/12 , C07D261/18 , C07D413/04 , C07D413/06 , C07F9/653 , C07D
Abstract: Novel 3,5-disubstituted 2-isoxazolines and isoxazoles and novel pharmaceuticals are described which are suitable, in particular, for the prophylaxis and/or treatment of pathological, neurodegenerative disorders in humans and animals. Processes for the preparation of these 3,5-disubstituted 2-isoxazolines and isoxazolines and isoxazoles are additionally indicated.
-
公开(公告)号:NZ226697A
公开(公告)日:1991-02-26
申请号:NZ22669788
申请日:1988-10-25
Applicant: HOECHST AG
Inventor: SCHWAB WILFRIED , BARTLETT ROBERT RYDER , GEBERT ULRICH , SCHORLEMMER HANS ULRICH , DICKNEITE GERHARD , SEDLACEK HANS HARALD
IPC: A61K31/675 , A61K39/39 , A61P35/00 , A61P37/00 , C07F9/40 , C07F9/547 , C07F9/653 , C07F9/6574 , C07F9/38 , C07F9/44 , C07D261/04 , C07D261/08 , C07D261/10 , C07D413/04 , C07D413/06 , A61K31/42
Abstract: The medicine contains or consists of at least one compound of the formula I and/or optionally one of its physiologically tolerated salts, where the compounds of the formula I can optionally be in the form of pure stereoisomers or mixtures thereof; formula I is: in which R = organic radical or halogen A = C,C single or C,C double bond, n = 0, 1 or 2 and X and Y = alkyl radical or = -OR or -NR R with R , R = H or optionally substituted aliphatic radical. The medicines are suitable for the prophylaxis and/or treatment of disorders of the immune system.
-
公开(公告)号:AU2419588A
公开(公告)日:1989-04-27
申请号:AU2419588
申请日:1988-10-25
Applicant: HOECHST AG
Inventor: SCHWAB WILFRIED , BARTLETT ROBERT RYDER , GEBERT ULRICH , SCHORLEMMER HANS ULRICH , DICKNEITE GERHARD , SEDLACEK HANS HARALD
IPC: A61K31/675 , A61K39/39 , A61P35/00 , A61P37/00 , C07F9/40 , C07F9/547 , C07F9/653 , C07F9/6574 , C07F9/65 , A61K31/685
Abstract: The medicine contains or consists of at least one compound of the formula I and/or optionally one of its physiologically tolerated salts, where the compounds of the formula I can optionally be in the form of pure stereoisomers or mixtures thereof; formula I is: in which R = organic radical or halogen A = C,C single or C,C double bond, n = 0, 1 or 2 and X and Y = alkyl radical or = -OR or -NR R with R , R = H or optionally substituted aliphatic radical. The medicines are suitable for the prophylaxis and/or treatment of disorders of the immune system.
-
公开(公告)号:AU575826B2
公开(公告)日:1988-08-11
申请号:AU2770684
申请日:1984-05-04
Applicant: HOECHST AG
Inventor: KIRRSTETTER REINER , SCHWAB WILFRIED , DURCKHEIMER WALTER , LATTRELL RUDOLF
IPC: A61K31/425 , A61K31/545 , C07D20060101 , C07D501/00 , C07D501/04 , C07D501/06 , C07D501/38 , C07D501/46 , C07D501/56 , C07D501/57 , C07D519/00
Abstract: Process for the preparation of cephem compounds of the formula wherein R is optionally substituted aminothiazolyl or amino-1,2,4-thiadiazolyl, A is optionally substituted pyridinium, R1 is hydrogen or methoxy and R2 are special aliphatic substituents, by a nucleophilic replacement in the substituent in 3-position in the presence of tri-C1C4-alkyl iodosilane.
-
公开(公告)号:CA1225954A
公开(公告)日:1987-08-25
申请号:CA453603
申请日:1984-05-04
Applicant: HOECHST AG
Inventor: LATTRELL RUDOLF , DUERCKHEIMER WALTER , KIRRSTETTER REINER , SCHWAB WILFRIED
IPC: C07D501/18 , C12P35/02 , C12P35/08
Abstract: HOE 83/F 079 of the disclosure: Process for the preparation of cephem compounds Process for the preparation of 7-amino-cephalos-poranic acid derivatives of the formula
-
公开(公告)号:AU6870087A
公开(公告)日:1987-08-13
申请号:AU6870087
申请日:1987-02-11
Applicant: HOECHST AG
Inventor: KOLLER KLAUS-PETER , SCHWAB WILFRIED
Abstract: Cesium chloride is recovered from used density gradient solutions by extraction of lipophilic and coloring components using a lipophilic solvent, subsequent extraction with a polar protic organic solvent, adding perchlorate ions to the extraction residue, and converting the precipitated cesium perchlorate into cesium chloride.
-
90.
公开(公告)号:CS249132B2
公开(公告)日:1987-03-12
申请号:CS980783
申请日:1983-12-22
Applicant: HOECHST AG
Inventor: LATTRELL RUDOLF , DUERCKHEIMER WALTER , KIRRSTETTER REINER , SCHWAB WILFRIED , KLESEL NORBERT
IPC: A01N20060101 , A01N43/78 , A01N43/86 , A61K20060101 , A61K31/545 , A61K31/546 , A61P31/04 , C07D20060101 , C07D501/20 , C07D501/46 , C07D501/56 , C07D501/57
Abstract: For the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE 1. Cephem derivatives of the general formula see diagramm : EP0111935,P10,F1 and physiologically acceptable acid addition salts thereof in which R**1 denotes hydrogen, R**2 denotes hydrogen, R**3 denotes C1 -C4 -alkyl optionally substituted by fluorine, A denotes a quinolinium or an isoquinolinium radical, each of which can also be substituted once or twice by C1 -C4 -alkyl and in which the R**3O group is in the syn position. For the Contracting State : AT A process for the preparation of cephem derivatives of the general formula I see diagramm : EP0111935,P11,F1 and physiologically acceptable acid addition salts thereof in which R**1 denotes hydrogen, R**2 denotes hydrogen, R**3 denotes C1 -C4 -alkyl optionally substituted by fluorine, A denotes a quinolinium or an isoquinolinium radical, each of which can also be substituted once or twice by C1 -C4 -alkyl and in which the R**3O group is in the syn position, which comprises a) reacting a compound of the general formula II see diagramm : EP0111935,P11,F2 or salts thereof or a reactive derivative of the compound II in which R**1, R**2 and R**3 have the abovementioned meaning and R**8 denotes an amino group or a protected amino group and R**9 denotes a group which can be replaced by quinoline, isoquinoline or substituted quinolines or isoquinolines corresponding to the radicals A of the formula I, with quinoline, isoquinoline or one of their derivatives, and alpha) splitting off a protective group which is present where appropriate and beta) if necessary, converting the resulting product into a physiologically acceptable acid addition salt, or b) reacting a 7-aminocephen compound of the general formula III see diagramm : EP0111935,P12,F3 or acid addition salts thereof in which R**2 and A have the abovementioned meaning, it also being possible for the amino group to be present in the form of a reactive derivative, with a 2-(2-aminothiazol-4-yl)-2-syn-oximinoacetic acid of the general formula IV see diagramm : EP0111935,P12,F4 in which R**1, R**3 and R**8 have the above meaning, or with an activated derivative of this compound, and alpha) splitting off a protective group which is present where appropriate and beta) if necessary, converting the resulting product into a physiologically acceptable acid addition salt
-
-
-
-
-
-
-
-
-